The Journal of Cardiovascular Aging,
Journal Year:
2025,
Volume and Issue:
5(1)
Published: March 20, 2025
Cardiovascular
diseases
(CVD)
remain
the
leading
cause
of
death
worldwide,
with
advancing
age
being
primary,
nonmodifiable
risk
factor.
Vascular
dysfunction,
namely
arterial
stiffening
and
endothelial
is
key
antecedent
to
development
clinical
CVD
aging.
Fundamental
aging
macro-mechanistic
processes
that
drive
vascular
include
excess
oxidative
stress,
chronic
inflammation,
declines
in
vasodilatory
molecule
nitric
oxide.
An
important
hallmark
contributes
cellular
senescence
-
a
stress
response
characterized
by
cell
cycle
arrest
accompanied
production
secretion
proinflammatory
molecules
(i.e.,
senescence-associated
secretory
phenotype
[SASP]).
Excess
senescent
cells
SASP
have
deleterious
effects
on
function
states
CVD,
making
it
putative
therapeutic
target
for
improving
preventing
or
reversing
CVD.
This
review
will
focus
role
age-related
dysfunction
We
examine
established
emerging
mechanisms
underlying
senescence-induced
dysfunction.
then
discuss
groups
impaired
high
burden
strategies
reduce
remove
who
are
likely
benefit
most
from
these
therapies.
Finally,
we
highlight
systemic
suppression
other
tissues
organs,
given
integrative
vasculature
physiology.
Together,
this
underscore
imperative
need
deeper
understanding
translational
use
targeting
therapies
burden.
Translational Neurodegeneration,
Journal Year:
2024,
Volume and Issue:
13(1)
Published: Feb. 20, 2024
Abstract
Brain
aging
is
a
recognized
risk
factor
for
neurodegenerative
diseases
like
Alzheimer's
disease,
Parkinson's
and
amyotrophic
lateral
sclerosis
(ALS,
Lou
Gehrig's
disease),
but
the
intricate
interplay
between
brain
pathogenesis
of
these
conditions
remains
inadequately
understood.
Cellular
senescence
considered
to
contribute
cellular
dysfunction
inflammaging.
According
threshold
theory
senescent
cell
accumulation,
vulnerability
associated
with
rates
generation
clearance
within
brain.
Given
role
microglia
in
eliminating
cells,
accumulation
may
lead
acceleration
aging,
contributing
inflammaging
increased
diseases.
In
this
review,
we
propose
idea
that
microglia,
which
notably
vulnerable
could
potentially
serve
as
central
catalyst
progression
The
are
emerging
promising
target
mitigating
International Journal of Molecular Sciences,
Journal Year:
2022,
Volume and Issue:
23(17), P. 10135 - 10135
Published: Sept. 4, 2022
Aging
causes
a
progressive
decline
in
the
structure
and
function
of
organs.
With
advancing
age,
an
accumulation
senescent
endothelial
cells
(ECs)
contributes
to
risk
developing
vascular
dysfunction
cardiovascular
diseases,
including
hypertension,
diabetes,
atherosclerosis,
neurodegeneration.
Senescent
ECs
undergo
phenotypic
changes
that
alter
pattern
expressed
proteins,
as
well
their
morphologies
functions,
have
been
linked
impairments,
such
aortic
stiffness,
enhanced
inflammation,
dysregulated
tone.
Numerous
molecules
pathways,
sirtuins,
Klotho,
RAAS,
IGFBP,
NRF2,
mTOR,
implicated
promoting
EC
senescence.
This
review
summarizes
molecular
players
signaling
pathways
driving
senescence
identifies
targets
with
possible
therapeutic
value
age-related
diseases.
Frontiers in Cardiovascular Medicine,
Journal Year:
2023,
Volume and Issue:
10
Published: March 2, 2023
Direct
antihypertensive
therapy
in
hypertensive
patients
with
a
high
CVD
risk
can
reduce
the
incidence
of
cardiovascular
death
but
increase
adverse
events,
so
additional
ways
to
identify
at
may
be
needed.
Studies
have
shown
that
immunity
and
inflammation
affect
prognoses
hypertension
pan-immune-inflammation
value
(PIV)
is
an
index
assess
inflammation,
few
studies
applied
PIV
hypertension.To
explore
relationship
between
long-term
all-cause
mortality
hypertension.Data
from
National
Health
Nutrition
Examination
Survey
(NHANES)
1999-2018
follow-up
through
December
31,
2019,
were
analyzed.
A
total
26,781
participants
evaluated.
The
grouped
based
on
levels
as
follows:
T1
group
(n
=
8,938),
T2
8,893),
T3
8,950).
was
assessed
by
survival
curves
Cox
regression
analysis
NHANES
recommended
weights.The
significantly
associated
hypertension.
After
full
adjustment,
higher
[Group
3:
HR:
1.37,
95%
CI:
1.20-1.55,
p
<
0.001]
1.62,
1.22-2.15,
mortality.Elevated
increased
patients.
International Journal of Molecular Sciences,
Journal Year:
2024,
Volume and Issue:
25(4), P. 1978 - 1978
Published: Feb. 6, 2024
Endothelial
cells
line
at
the
most
inner
layer
of
blood
vessels.
They
act
to
control
hemostasis,
arterial
tone/reactivity,
wound
healing,
tissue
oxygen,
and
nutrient
supply.
With
age,
endothelial
become
senescent,
characterized
by
reduced
regeneration
capacity,
inflammation,
abnormal
secretory
profile.
senescence
represents
one
earliest
features
ageing
contributes
many
age-related
diseases.
Compared
those
in
arteries
veins,
microcirculation
exhibit
a
greater
extent
heterogeneity.
Microcirculatory
leads
declined
capillary
density,
angiogenic
potentials,
decreased
flow,
impaired
barrier
properties,
hypoperfusion
or
organ-dependent
manner.
The
heterogeneous
phenotypes
microvascular
particular
vascular
bed
across
different
tissues
remain
largely
unknown.
Accordingly,
mechanisms
underlying
macro-
micro-vascular
vary
pathophysiological
conditions,
thus
offering
specific
target(s)
for
therapeutic
development
senolytic
drugs.
Cells,
Journal Year:
2022,
Volume and Issue:
12(1), P. 106 - 106
Published: Dec. 27, 2022
A
senescence-associated
secretory
phenotype
(SASP)
and
a
mild
inflammatory
response
characteristic
of
senescent
cells
(inflammaging)
form
the
conditions
for
development
cardiovascular
diseases:
atherosclerosis,
coronary
heart
disease,
myocardial
infarction.
The
purpose
review
is
to
analyze
pool
signaling
molecules
that
SASP
inflammaging
in
system
search
targets
action
vasoprotective
peptides.
characterized
by
change
synthesis
anti-proliferative
proteins
(p16,
p19,
p21,
p38,
p53),
cytokines
(IL-1α,β,
IL-4,
IL-6,
IL-8,
IL-18,
TNFα,
TGFβ1,
NF-κB,
MCP),
matrix
metalloproteinases,
adhesion
molecules,
sirtuins.
It
has
been
established
peptides
are
physiological
regulators
body
functions.
Vasoprotective
polypeptides
(liraglutide,
atrial
natriuretic
peptide,
mimetics
relaxin,
Ucn1,
adropin),
KED
tripeptide,
AEDR
tetrapeptide
regulate
involved
SASP-forming
system.
This
indicates
prospects
drugs
based
on
treatment
age-associated
pathology.
Calcified Tissue International,
Journal Year:
2023,
Volume and Issue:
113(1), P. 68 - 82
Published: May 31, 2023
Abstract
Senescence
is
a
complex
cell
state
characterized
by
stable
cycle
arrest
and
unique
secretory
pattern
known
as
the
senescence-associated
phenotype
(SASP).
The
SASP
factors,
which
are
heterogeneous
tissue
specific,
normally
include
chemokines,
cytokines,
growth
adhesion
molecules,
lipid
components
that
can
lead
to
multiple
age-associated
disorders
eliciting
local
systemic
consequences.
skeleton
highly
dynamic
organ
changes
constantly
in
shape
composition.
Senescent
cells
bone
marrow
produce
diverse
factors
induce
alterations
of
through
paracrine
effects.
Herein,
we
refer
cell-associated
“bone-SASP.”
In
this
review,
describe
current
knowledge
cellular
senescence
SASP,
focusing
on
role
senescent
mediating
pathologies
during
natural
aging
premature
syndromes.
We
also
summarize
bone-SASP
glucocorticoids-induced
damage.
addition,
discuss
development
osteoarthritis,
highlighting
mechanisms
drives
subchondral
metabolic
syndrome-associated
osteoarthritis.
Journal of Alzheimer s Disease,
Journal Year:
2023,
Volume and Issue:
95(2), P. 493 - 507
Published: Aug. 4, 2023
Background:
The
existence
and
contribution
of
microglia
with
senescent-like
alterations
in
the
pathogenesis
age-related
neurodegenerative
diseases
like
Alzheimer’s
disease
(AD)
have
been
suggested
recent
years.
However,
identification
this
distinct
microglial
population
vivo
has
proven
challenging,
largely
due
to
overlaps
inflammatory
phenotype
activated
senescent
microglia.
Furthermore,
attempts
at
recapitulating
senescence
vitro
are
limited.
Objective:
To
identify
characterize
that
occur
an
animal
model
neurodegeneration
driven
by
pathologic
tau.
Methods:
We
analyzed
RNA
expression
patterns
individual
from
normal
mice
pathogenic
tau
P301
S
PS19
mouse
model.
previously
demonstrated
p16-expressing
these
when
occurred.
Results:
Here
we
a
subset
disease-associated
features,
notably
characterized
Ccl4.
This
signature
established
markers
other
cell
types.
Conclusion:
Our
characterization
can
be
used
better
understand
role
various
contexts,
including
whether
clearance
represents
viable
therapeutic
option.